AI
AMGN icon

AXS Investments’s Amgen AMGN Stock Holding History

AXS Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Sell
82
-7
-8% -$2.4K 0.01% 174
2026
Q1 		$31.3K Sell
89
-26
-23% -$9.27K 0.01% 172
2025
Q4 		$37.6K Sell
115
-35
-23% -$11.1K 0.01% 178
2025
Q3 		$42.3K Buy
+150
New +$43.5K 0.01% 181
2025
Q2 		– Sell
-4,290
Closed -$1.34M – 150
2025
Q1 		$1.34M Sell
4,290
-769
-15% -$227K 0.37% 113
2024
Q4 		$1.32M Buy
5,059
+1,148
+29% +$341K 0.37% 121
2024
Q3 		$1.26M Sell
3,911
-39
-1% -$12.8K 0.33% 162
2024
Q2 		$1.23M Sell
3,950
-788
-17% -$231K 0.34% 118
2024
Q1 		$1.35M Buy
4,738
+105
+2% +$30.7K 0.32% 107
2023
Q4 		$1.33M Sell
4,633
-227
-5% -$61.9K 0.32% 121
2023
Q3 		$1.31M Buy
4,860
+4,733
+3,727% +$1.18M 0.34% 83
2023
Q2 		$28.2K Sell
127
-24
-16% -$5.57K 0.01% 369
2023
Q1 		$36.5K Buy
151
+25
+20% +$6.14K 0.01% 319
2022
Q4 		$33.1K Buy
+126
New +$33.8K 0.01% 303

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AXS Investments's AMGN Position: Q2 2026 in Review

AXS Investments reduced its Amgen (AMGN) stake by 7.9% in Q2 2026, selling an estimated $2.4K and leaving 82 shares worth $29.7K. The position accounts for 0.01% of the portfolio, ranked #174.

AXS Investments first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.35M in Q1 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AXS Investments held 82 shares of Amgen worth $29.7K as of Q2 2026.
  • AXS Investments sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.01% of AXS Investments's portfolio in Q2 2026, its #174 holding.
  • AXS Investments first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • AXS Investments's Amgen position peaked at $1.35M in Q1 2024.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.